ADVISORY, Nov. 14, 2017 (GLOBE NEWSWIRE) -- What: Deciphera Pharmaceuticals, Inc. (Nasdaq:DCPH), a clinical-stage biopharmaceutical company focused on developing novel treatments to improve the lives of cancer patients, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, Daniel L. Flynn, Ph.D., Chief Scientific Officer and Founder, will ring the Opening Bell. Where: Nasdaq MarketSite - 4 Times Square - 43 & Broadway - Broadcast Studio When: Wednesday, November 15, 2017 - 9:15 a.m. to 9:30 a.m. ET Deciphera Pharmaceuticals, Inc. Media Contact: Gina Nugent (617) 460-3579 gina@theyatesnetwork.com Nasdaq MarketSite Media Contact: Emily Pan (646) 441-5120...
|
